Literature DB >> 19234652

Outcomes in patients with popliteal sarcomas.

Robert E Turcotte1, Marco Ferrone, Marc H Isler, Cynthia Wong.   

Abstract

BACKGROUND: Soft-tissue sarcoma involving the popliteal fossa remains challenging because it is difficult to achieve wide margins with limb salvage in this location. Adjuvant therapy is frequently necessary, and limb function can be adversely affected. We reviewed our experience with these tumours.
METHODS: Our prospective tumour database served to identify all patients with popliteal sarcomas treated at the McGill University Health Centre and the Maisonneuve-Rosemont Hospital between 1994 and 2005. We assessed oncologic and functional outcomes as well as complications.
RESULTS: Our study included 18 patients (12 women and 6 men). The mean age was 54 (range 16-84) years. The mean duration of follow-up was 55 (range 4-126) months. Frequent histologic diagnoses were liposarcoma (n = 6), synovial sarcoma (n = 4) and leiomyosarcoma (n = 3). Tumour size varied from 2 to 21 cm (median 11 cm). American Joint Committee on Cancer staging was as follows: 4 patients had stage IIa disease, 3 patients had stage IIb, 10 patients had stage III and 1 patient had stage IV disease. Treatment consisted of limb salvage in 15 patients and amputation in 3. Fourteen patients had radiotherapy, 4 had chemotherapy, and 3 needed partial sciatic nerve resection. Margins were negative in 7 of 18 patients and microscopically positive in 11 patients. Complications included wound infections in 3 patients and thrombophlebitis in 2 patients. Of the patients undergoing limb-salvaging procedures, 1 experienced local recurrences after limb salvage (7%), and 5 experienced lung metastases (20%). Local recurrence was always associated with positive margins, whereas metastases occurred only in patients without local recurrence. The mean Musculoskeletal Tumor Society 1987 score was 33 (range 24-35). The mean Toronto Extremity Salvage Score results was 82.4 (range 63.8-100). At latest follow-up, 6 patients had died of disease, 1 was alive with disease, and 11 (61%) patients remained free of disease.
CONCLUSION: Despite the high rate of microscopically positive margins, the local recurrence rate was 7%. Amputation did not prevent death. We found function to be good to excellent in most patients who had limb-salvaging surgery.

Entities:  

Mesh:

Year:  2009        PMID: 19234652      PMCID: PMC2637647     

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  27 in total

1.  Soft tissue sarcomas of the popliteal fossa: outcome and risk factors.

Authors:  H A Rüdiger; G Beltrami; D A Campanacci; M M Mela; A Franchi; R Capanna
Journal:  Eur J Surg Oncol       Date:  2006-12-15       Impact factor: 4.424

2.  The problem of local recurrence after treatment of soft tissue sarcoma.

Authors:  J Cantin; G P McNeer; F C Chu; R J Booher
Journal:  Ann Surg       Date:  1968-07       Impact factor: 12.969

Review 3.  Current concepts review. The surgical staging of musculoskeletal sarcoma.

Authors:  W F Enneking; S S Spanier; M A Goodman
Journal:  J Bone Joint Surg Am       Date:  1980-09       Impact factor: 5.284

4.  The effect of the Anatomic setting on the results of surgical procedures for soft parts sarcoma of the thigh.

Authors:  W F Enneking; S S Spanier; M M Malawer
Journal:  Cancer       Date:  1981-03-01       Impact factor: 6.860

5.  Local recurrence of deep-seated, high-grade, soft tissue sarcoma: 459 patients from the Scandinavian Sarcoma Group Register.

Authors:  C S Trovik; H C Bauer; O Berlin; E Tukiainen; M Erlanson; P Gustafson; R Klepp; G Saeter; O Wahlström
Journal:  Acta Orthop Scand       Date:  2001-04

6.  Predictors of functional outcomes following limb salvage surgery for lower-extremity soft tissue sarcoma.

Authors:  A M Davis; S Sennik; A M Griffin; J S Wunder; B O'Sullivan; C N Catton; R S Bell
Journal:  J Surg Oncol       Date:  2000-04       Impact factor: 3.454

7.  The influence of anatomic location on functional outcome in lower-extremity soft-tissue sarcoma.

Authors:  C H Gerrand; J S Wunder; R A Kandel; B O'Sullivan; C N Catton; R S Bell; A M Griffin; A M Davis
Journal:  Ann Surg Oncol       Date:  2004-04-12       Impact factor: 5.344

8.  Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial.

Authors:  Brian O'Sullivan; Aileen M Davis; Robert Turcotte; Robert Bell; Charles Catton; Pierre Chabot; Jay Wunder; Rita Kandel; Karen Goddard; Anna Sadura; Joseph Pater; Benny Zee
Journal:  Lancet       Date:  2002-06-29       Impact factor: 79.321

9.  Limb preservation and tumor control in the treatment of popliteal and antecubital soft tissue sarcomas.

Authors:  M H Shiu; C Collin; B S Hilaris; D Nori; S Manolatos; L L Anderson; S I Hajdu; J M Lane; S Hopfan; M F Brennan
Journal:  Cancer       Date:  1986-04-15       Impact factor: 6.860

10.  A system of staging musculoskeletal neoplasms.

Authors:  W F Enneking
Journal:  Clin Orthop Relat Res       Date:  1986-03       Impact factor: 4.176

View more
  7 in total

1.  [Surgical margins in soft tissue sarcoma of the extremities].

Authors:  H-U Steinau; L Steinsträsser; S Langer; I Stricker; O Goertz
Journal:  Pathologe       Date:  2011-02       Impact factor: 1.011

2.  High-grade intra-articular liposarcoma of the knee.

Authors:  Daniel A Shaerf; Bhupinder Mann; Mohammed Alorjani; Will Aston; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2010-12-21       Impact factor: 2.199

3.  The treatment of periarticular soft tissue sarcoma following neo-adjuvant radiotherapy: a cohort study.

Authors:  Carl M Green; Nam Nguyen; James Wylie; Ananya Choudhury; Jonathan J Gregory
Journal:  World J Surg Oncol       Date:  2015-03-14       Impact factor: 2.754

4.  3-Dimensional micropillar drug screening identifies FGFR2-IIIC overexpression as a potential target in metastatic giant cell tumor.

Authors:  Seung Tae Kim; Jusun Kim; Sumin Shin; Sun Young Kim; Dongwoo Lee; Bosung Ku; Yong Sung Shin; Jhingook Kim; Jeeyun Lee
Journal:  Oncotarget       Date:  2017-05-30

5.  Investigation of FGFR2-IIIC signaling via FGF-2 ligand for advancing GCT stromal cell differentiation.

Authors:  Shalini Singh; Mohini Singh; Isabella W Y Mak; Robert Turcotte; Michelle Ghert
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

6.  Expressional Analysis of GFP-Tagged Cells in an In Vivo Mouse Model of Giant Cell Tumor of Bone.

Authors:  S Singh; M Singh; I Mak; M Ghert
Journal:  Open Orthop J       Date:  2013-05-03

7.  A systematic review of the recent quality of life studies in adult extremity sarcoma survivors.

Authors:  Melissa H Tang; Donald J W Pan; David J Castle; Peter F M Choong
Journal:  Sarcoma       Date:  2012-08-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.